Geode Capital Management, LLC Maia Biotechnology, Inc. Put Options Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MAIA
# of Institutions
21Shares Held
1.23MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA650KShares$1.09 Million0.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$131,1300.0% of portfolio
-
Centric Wealth Management68.2KShares$113,9740.03% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA55.1KShares$92,0170.0% of portfolio
-
State Street Corp Boston, MA53.3KShares$88,9270.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $18.3M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...